{
    "doi": "https://doi.org/10.1182/blood.V122.21.4871.4871",
    "article_title": "Paroxysmal Nocturnal Hemoglobinuria and Cancer: High Incidence Of Cancer In a Large Series Of PNH Patients In a Single Center ",
    "article_date": "November 15, 2013",
    "session_type": "508 - Bone Marrow Failure",
    "abstract_text": "Since 1964, a total of 56 patients with Paroxysmal Nocturnal Hemoglobinuria clone (PNH) were evaluated in our Hematology Unit. The PNH was evaluated with Ham\u2019s and/or sucrose tests until 1993, when the firsts cytometric analysis of PNH were performed in our Laboratory with CD55 and CD59 markers on granulocytes mainly, and since 2011 also with the FLAER technique. According with PNH Parker\u00b4s Classification, most of the patients were Classical PNH type (28 patients), and the remaining included in the other subsets such as 21 PNH in the setting of another bone marrow failure syndrome (BMFS) and 7 PNH subclinical. Most of the patients (70%) displayed an Aplastic Anemia (AA) before or concomitantly with the diagnosis of PNH, and received immunosuppressant drugs (Steroids with/out antithymocyte globulin & Cyclosporine). In four patients an Allogeneic Hematopoietic Transplantation was performed due to a Severe Aplastic Anemia (2 patients), a Classical Severe PNH (before Eculizumab era) or a Myelodysplastic Syndrome. Another patient received a Liver Transplantation because of advanced Hepatitis C related liver failure. In our PNH series, an unexpected high incidence of cancer has appeared, with 8 patients (14,5%) displaying different hematological or non-hematological cancers in the lasts years:  Sex . Age Diagnosis PNH . Parker\u2019s Classification . Year Diagnosis PNH . Year Diagnosis Cancer . Previous Immunosuppression . Cancer . Year Death . \u2642 16 Classical 1969 2011 Yes Lymphoma 2011 AA & Liver Tx \u2640 30 Classical 1973 2003 None Pancreatic 2006 \u2642 38 Classical 1974 1995 None Gastric 2012 2012 Pulmonary \u2642 26 Classical 1989 2013 Yes, Steroids Cerebral Alive \u2640 25 Classical 1994 2005 Yes Lymphoma 2006 AA & Cord-Blood Tx \u2642 40 BMFS 1995 1995 Yes, Steroids Liver 1995 \u2642 75 BMFS 2011 2009 None Seminoma 2012 *  \u2642 56 Subclinical 2010 1999 Yes, Steroids Prostatic Alive Sex . Age Diagnosis PNH . Parker\u2019s Classification . Year Diagnosis PNH . Year Diagnosis Cancer . Previous Immunosuppression . Cancer . Year Death . \u2642 16 Classical 1969 2011 Yes Lymphoma 2011 AA & Liver Tx \u2640 30 Classical 1973 2003 None Pancreatic 2006 \u2642 38 Classical 1974 1995 None Gastric 2012 2012 Pulmonary \u2642 26 Classical 1989 2013 Yes, Steroids Cerebral Alive \u2640 25 Classical 1994 2005 Yes Lymphoma 2006 AA & Cord-Blood Tx \u2642 40 BMFS 1995 1995 Yes, Steroids Liver 1995 \u2642 75 BMFS 2011 2009 None Seminoma 2012 *  \u2642 56 Subclinical 2010 1999 Yes, Steroids Prostatic Alive * Dead because bone marrow failure. View Large In our PNH series, cancer reports as one of the most frequent final cause of death, with thrombosis with similar incidence (11 patients of the 56 are dead, with 5 patients dead because thrombosis), although the high incidence and severity of thrombosis episodes in this cohort of patients (20 patients experienced thrombosis with a total of 40 events). As displayed supra, some of the cancers could be attributed to the therapy applied in particular patients: The two secondary lymphomas after organ transplantation could be explained by the immunosuppression employed in these procedures. Only three patients did not received immunosuppressant drugs before cancer diagnosis. This high mortality cancer rate precludes the indiscriminate use of steroids in PNH patients. This result, never reported before in PNH, merits an investigational survey of cancer incidence in PNH patients in the PNH International Registry. Disclosures: Ojeda: Alexion Pharmaceuticals: Consultancy, Speakers Bureau.",
    "topics": [
        "cancer",
        "paroxysmal nocturnal hemoglobinuria",
        "steroids",
        "thrombosis",
        "lymphoma",
        "aplastic anemia",
        "cancer diagnosis",
        "immunosuppressive agents",
        "pancytopenia",
        "therapeutic immunosuppression"
    ],
    "author_names": [
        "Cristina Mu\u00f1oz-Linares, MD",
        "Emilio Ojeda, MD, PhD",
        "Rafael Fores, MD",
        "Martin Cabero, MD",
        "Daniel Morillo, MD",
        "Guiomar Bautista, MD",
        "Belen Navarro, MD",
        "Isabel Krsnik, MD, PhD",
        "Santiago Gil, MD, PhD",
        "Almudena de LaIglesia, MD",
        "Carmen Regidor, MD, PhD",
        "Jose Luis Bueno, MD",
        "Jose A Garcia-Marco, MD, PhD",
        "Jose Rafael Cabrera, MD, PhD"
    ],
    "author_dict_list": [
        {
            "author_name": "Cristina Mu\u00f1oz-Linares, MD",
            "author_affiliations": [
                "Hematology, Hospital Puerta de Hierro Majadahonda, Majadahonda, Spain"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Emilio Ojeda, MD, PhD",
            "author_affiliations": [
                "Hematology, Hospital Puerta de Hierro Majadahonda, Majadahonda, Spain"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Rafael Fores, MD",
            "author_affiliations": [
                "Hematology, Hospital Puerta de Hierro Majadahonda, Majadahonda, Spain"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Martin Cabero, MD",
            "author_affiliations": [
                "Hematology, Hospital Puerta de Hierro Majadahonda, Majadahonda, Spain"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Daniel Morillo, MD",
            "author_affiliations": [
                "Hematology, Hospital Puerta de Hierro Majadahonda, Majadahonda, Spain"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Guiomar Bautista, MD",
            "author_affiliations": [
                "Hematology, Hospital Puerta de Hierro Majadahonda, Majadahonda, Spain"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Belen Navarro, MD",
            "author_affiliations": [
                "Hematology, Hospital Puerta de Hierro Majadahonda, Majadahonda, Spain"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Isabel Krsnik, MD, PhD",
            "author_affiliations": [
                "Hematology, Hospital Puerta de Hierro Majadahonda, Majadahonda, Spain"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Santiago Gil, MD, PhD",
            "author_affiliations": [
                "Hematology, Hospital Puerta de Hierro Majadahonda, Majadahonda, Spain"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Almudena de LaIglesia, MD",
            "author_affiliations": [
                "Hematology, Hospital Puerta de Hierro Majadahonda, Majadahonda, Spain"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carmen Regidor, MD, PhD",
            "author_affiliations": [
                "Hematology, Hospital Puerta de Hierro Majadahonda, Majadahonda, Spain"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jose Luis Bueno, MD",
            "author_affiliations": [
                "Hematology, Hospital Puerta de Hierro Majadahonda, Majadahonda, Spain"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jose A Garcia-Marco, MD, PhD",
            "author_affiliations": [
                "Hematology, Hospital Puerta de Hierro Majadahonda, Majadahonda, Spain"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jose Rafael Cabrera, MD, PhD",
            "author_affiliations": [
                "Hematology, Hospital Puerta de Hierro Majadahonda, Majadahonda, Spain"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-27T21:40:01",
    "is_scraped": "1"
}